Arjuna Capital

Position in NVS — Novartis AG

CIK 1703208 MANCHESTER, MA

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,543,156

+$417,532 QoQ

Shares Held

28,989

+7.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.18%

of 13F equity value

Holder Rank

#276

of 1,603 holders

Holding Since

Mar 2020

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Arjuna Capital holds $20,631,399 across 5 Drug Manufacturers - General names. NVS ranks #3 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	135,511	$7,103,486
2	LLY	ELI LILLY & Co	4,447	$5,333,865
3	NVS	Novartis AG This page	28,989	$4,543,156
4	AMGN	Amgen Inc	6,166	$2,232,831
5	SNY	Sanofi	33,241	$1,418,061

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,543,156	28,989	+7.3%	Shares	Sole	2026-08-14
2026-03-31	$4,125,624	27,009	+9.3%	Shares	Sole	2026-05-06
2025-12-31	$3,406,078	24,705	-0.6%	Shares	Sole	2026-02-05
2025-09-30	$3,186,892	24,851	+109.0%	Shares	Sole	2025-11-04
2025-06-30	$1,439,050	11,892	-4.5%	Shares	Sole	2025-08-13
2025-03-31	$1,387,591	12,447	-5.0%	Shares	Sole	2025-05-09
2024-12-31	$1,275,344	13,106	-1.5%	Shares	Sole	2025-02-07
2024-09-30	$1,530,226	13,304	+0.5%	Shares	Sole	2024-11-05
2024-06-30	$1,408,998	13,235	+0.2%	Shares	Sole	2024-07-29
2024-03-31	$1,277,222	13,204	-42.9%	Shares	Sole	2024-05-13
2023-12-31	$2,335,537	23,131	+4.8%	Shares	Sole	2024-02-08
2023-09-30	$2,247,337	22,063	+125.5%	Shares	Sole	2023-11-09
2021-09-30	$799,971	9,782	-1.7%	Shares	Sole	2021-11-08
2021-06-30	$908,020	9,952	+2.3%	Shares	Sole	2021-08-11
2021-03-31	$831,720	9,730	+4.7%	Shares	Sole	2021-05-11
2020-12-31	$877,537	9,293	+5.4%	Shares	Sole	2021-02-09
2020-09-30	$766,639	8,816	+1.6%	Shares	Sole	2020-11-05
2020-06-30	$757,587	8,674	+2.2%	Shares	Sole	2020-08-13
2020-03-31	$699,753	8,487	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.